molecular clues help refine kinase inhibitor strategy for gi
Published 16 years ago • 1.3K plays • Length 10:57Download video MP4
Download video MP3
Similar videos
-
3:57
novel kinase inhibitor promising in nsclc
-
3:02
serum imatinib (gleevec) levels predict gist response
-
0:55
tyrosine kinase inhibitors
-
1:20
tyrosine kinase inhibitors
-
2:43
toxicity management for gist third-line therapy
-
2:23
the future of tyrosine kinase inhibitors for melanoma and open questions
-
12:21
gastric mass schema
-
1:03
the role of tkis in the management of hepatocellular carcinoma
-
1:09
ripretinib in uk patients with advanced gist
-
2:55
paul barr, md: use of bruton's tyrosine kinase inhibitor
-
0:59
ponatinib in advanced gists
-
5:34
second-generation tyrosine kinase inhibitors in chronic myelogenous leukemia
-
5:41
tyrosine kinase inhibitor in combination with chemo shows benefit in acute myeloid leukaemia
-
3:24
asco: longer tx lengthens life in gist
-
2:34
asco: bone effects fuel optimism for prostate ca drug
-
3:05
safety and efficacy of a newer tki for fourth-line gist
-
4:33
optimizing discontinuation of tyrosine kinase inhibitor treatment for chronic myeloid leukemia
-
3:02
eccmid 2018 - analyst bill quirk assesses new trends in molecular diagnostics
-
2:28
hypertension induced by tyrosine kinase inhibitor